government
publication date
CFO
Terrified of Tariffs? Read This.
CFOs are strategizing to protect their supply chains from drastic price hikes and product shortages.
Payer
Mostly False: Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
Under a new executive order, prescription drug prices will be reduced 'almost immediately.' ? President Donald Trump, in a May...
Revenue Cycle
Infographic: 4 Stats on the 340B Drug Pricing Program
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the...
CFO
Denied and Defiant: CFOs Must Muscle Up as Payers Get Tougher on Claims
Payer challenges are growing. Here's what CFOs are saying, and what they can do.
Pharma
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
Pharmacists find themselves on the front lines of a tariff storm.
Revenue Cycle
Senate Report Calls for Reforms to 340B Drug Pricing Program
Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual...
CFO
A CFO's Guide to Navigating Potential Medicaid Cuts
Medicaid cuts would severely damage access to healthcare, and healthcare leaders are speaking up.
Innovation
Congress Eyes Reimbursement Boost for Rural RPM Programs
A bill introduced in both the Senate and House would Improve Medicare reimbursement for rural providers using RPM technology.
CFO
Strategizing Through The Noise: 3 CFO Priorities in 2025
Private equity is reshaping healthcare, pushing CFOs to rethink strategy, investment, and workforce priorities.
Payer
SDOH in the Anti-DEI Era: The New Call to Action
Payers are facing possible CMS funding cuts to Medicaid waiver programs and possible threats to SDOH data collection.
Revenue Cycle
Infographic: What's Ahead for the 340B Drug Pricing Program?
The heavily scrutinized 340B Drug Pricing Program is back in the spotlight as the Trump administration targets drug costs in...